Ovid Therapeutics Inc (NASDAQ:OVID)

1.80
Delayed Data
As of Dec 05
 -0.05 / -2.70%
Today’s Change
1.41
Today|||52-Week Range
3.60
-43.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization11.8K56.5K80.3K141.7K
 
 
 
 
 
 
Operating ExpensesGross Income-11.8K-56.5K-80.3K-141.7K
 
 
 
 
 
General Expenses13.2M22.5M64.9M52.8M
 
 
 
 
 
Research And Development6.6M9.6M50.0M33.8M
 
 
 
 
 
Total Operating Expenses13.2M22.5M65.0M52.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.2M-22.5M-65.0M-52.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.2M-22.4M-64.8M-52.0M
 
 
 
 
 
Net Income-13.2M-22.4M-64.8M-52.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.4M25.4M19.3M24.6M
 
 
 
 
 
Shares To Calculate EPS Diluted25.4M25.4M19.3M24.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.36-$2.28-$3.35-$2.11
 
 
 
 
 
EPS Diluted-$0.52-$0.88-$3.35-$2.11